The Financial News 247The Financial News 247
  • Home
  • News
  • Business
  • Finance
  • Companies
  • Investing
  • Markets
  • Lifestyle
  • Tech
  • More
    • Opinion
    • Climate
    • Web Stories
    • Spotlight
    • Press Release
What's On
Allocate or avoid? Advisors weigh in on the recent gold rush

Allocate or avoid? Advisors weigh in on the recent gold rush

May 13, 2025
Automation, Amid Manufacturing Uncertainty, Hits The Accelerator

Automation, Amid Manufacturing Uncertainty, Hits The Accelerator

May 13, 2025
Patriots’ Milton Williams Ready To Run Through The Finish Line

Patriots’ Milton Williams Ready To Run Through The Finish Line

May 13, 2025
India considering tariffs on US goods to counter Trump’s levies

India considering tariffs on US goods to counter Trump’s levies

May 13, 2025
Advice helps clients recover from dire straits

Advice helps clients recover from dire straits

May 13, 2025
Facebook X (Twitter) Instagram
The Financial News 247The Financial News 247
Demo
  • Home
  • News
  • Business
  • Finance
  • Companies
  • Investing
  • Markets
  • Lifestyle
  • Tech
  • More
    • Opinion
    • Climate
    • Web Stories
    • Spotlight
    • Press Release
The Financial News 247The Financial News 247
Home » What It Can Do And Where It’s Heading

What It Can Do And Where It’s Heading

By News RoomMay 10, 2025No Comments5 Mins Read
Facebook Twitter Pinterest LinkedIn WhatsApp Telegram Reddit Email Tumblr
What It Can Do And Where It’s Heading
Share
Facebook Twitter LinkedIn Pinterest Email

Erez Meltzer, CEO & Board Member of Nanox, is a prominent Israel business leader with 35+ years experience leading various global companies.

Over the past five years, healthcare AI has evolved from experimental pilots to mainstream implementation.

AI is now part of daily patient care, for example, streamlining workflows and improving diagnostics and treatment decisions. Researchers at Yale School of Medicine and Johns Hopkins University found that AI-assisted triage at hospitals reduced discharge times by 82 minutes on average. In clinical trial settings at the NIH, AI-assisted screening decreased clinician workload by 40%, improving efficiency without compromising accuracy.

Beyond clinical settings, AI is revolutionizing healthcare operations: Sanofi and Aily Labs developed an algorithm that forecasts 80% of potential inventory shortages, fundamentally strengthening pharmaceutical supply chains.

Hospitals are already deploying AI to improve patient outcomes. One standout example is Kansas City’s Saint Luke’s Health System. After implementing Epic’s Early Detection of Sepsis system, they achieved a 32% reduction in order-to-antibiotic turnaround time and a 16% decrease in mortality index—translating directly to lives saved.

Similarly, AI has increased diagnostic precision, particularly in predicting cancer development or detecting cancers at earlier, more treatable stages. Researchers at the Massachusetts Institute of Technology demonstrated AI’s potential by developing a model that predicts breast cancer development up to five years in advance with 31% accuracy, significantly outperforming traditional methods’ 18% accuracy rate.

Despite these encouraging results, the last five years have also exposed critical barriers that healthcare leaders must overcome. Real-world applications have revealed that the success of AI in healthcare is influenced more by human factors, organizational readiness, regulatory challenges and infrastructure than by the technology itself.

Implementation Challenges

Fragmented data and privacy concerns hinder AI’s full potential. Many hospitals and clinics still operate in silos, limiting the ability of AI systems to access the complete datasets they need to deliver good results.

Beyond technical barriers, regulatory hurdles present significant challenges. Healthcare AI requires navigating complex approval processes from agencies like the FDA, which are still developing frameworks for evaluating AI-based medical technologies.

Early on, many clinicians viewed AI as a potential threat to their roles, creating resistance to adoption. Yet successful implementations have shown that AI isn’t about replacing human expertise but enhancing it. Educational initiatives and close collaboration between AI developers and healthcare staff will be instrumental in building trust and buy-in.

The True Investment Required

While AI’s promise is clear, organizations often underestimate the true cost of implementation, far beyond software licenses and hardware upgrades.

Even organizations with robust IT departments find that AI requires specialized infrastructure that exceeds standard technology implementations. Many assume AI is a simple plug-and-play process, but success requires significant infrastructure upgrades, compliance adjustments and workforce training.

AI implementation in the patient care sector often costs between $20,000 and $1,000,000. Staff training is another hidden expense that’s often overlooked, but it’s critical. While over 57% of healthcare workers report feeling comfortable using AI tools in their daily tasks, this leaves nearly half of the workforce lacking confidence. Bridging this gap demands comprehensive training programs and ongoing support.

Implementation timelines are a third critical disconnect between expectations and reality. Many organizations envision a rapid rollout of AI solutions, only to face delays that can stretch much longer than planned.

Measuring AI’s Impact

Ultimately, the success of AI in healthcare isn’t measured by its sophistication; it’s measured by its impact on patient outcomes. AI helped healthcare workers detect 20% more cases of breast cancer, for example, without increasing false positives and reducing clinician workloads by 44%.

Financially, AI can be costly upfront, but its long-term efficiencies drive significant cost savings. More fundamentally, AI is driving healthcare’s long-awaited shift from reactive to preventive care. By spotting subtle patterns in patient data that humans might miss, these systems can flag individuals at risk for serious conditions before symptoms even appear. One study estimates that broader adoption of AI in healthcare could lead to savings between 5% and 10% in U.S. healthcare spending, equating to approximately $200 billion to $360 billion annually.

For healthcare organizations, these efficiencies translate to a clear return on investment (ROI), not only through cost reduction but also by improving patient outcomes, resource allocation and creating new revenue. Integrated delivery networks (IDNs) and hospitals using AI can identify high-risk patients earlier, leading to better disease management and fewer complications.

The Road Ahead

Looking forward, one of the biggest emerging challenges is getting multiple AI tools to work together. Clinician skepticism due to concerns about explainability, biases and automation risks is a growing challenge, and too much reliance on AI could lead to skills degradation, where healthcare workers may lose critical thinking skills needed for independent decision-making.

However, when implemented responsibly, AI can enhance the quality of life and longevity, particularly for the elderly, by enabling earlier interventions, more personalized treatment plans and proactive disease prevention. This shift benefits not just patients but also insurers, who stand to save significantly when diseases are prevented or caught at earlier, more treatable stages.

AI will continue to impact healthcare, but its greatest value lies in complementing, not replacing, clinicians. The lessons from these first five years of implementation make the path forward clear: Healthcare organizations must prioritize interoperability, invest in comprehensive training and ensure AI serves real clinical needs rather than technology for technology’s sake.

Forbes Technology Council is an invitation-only community for world-class CIOs, CTOs and technology executives. Do I qualify?

Erez Meltzer
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Related News

Automation, Amid Manufacturing Uncertainty, Hits The Accelerator

Automation, Amid Manufacturing Uncertainty, Hits The Accelerator

May 13, 2025
Fashion, Not Features, Will Drive The Next Smartphone Revolution

Fashion, Not Features, Will Drive The Next Smartphone Revolution

May 13, 2025
Switch 2 Game Format Leak Reveals That Nintendo’s Old Habits Die Hard

Switch 2 Game Format Leak Reveals That Nintendo’s Old Habits Die Hard

May 13, 2025
How Tech Teams Can Manage Vacation Plans Without Disrupting Workflows

How Tech Teams Can Manage Vacation Plans Without Disrupting Workflows

May 13, 2025
‘Quordle’ Hints And Answers For Wednesday, May 14

‘Quordle’ Hints And Answers For Wednesday, May 14

May 13, 2025
Anonymizing Data For AI: Protect Privacy, Preserve Value

Anonymizing Data For AI: Protect Privacy, Preserve Value

May 13, 2025
Add A Comment

Leave A Reply Cancel Reply

Don't Miss
Automation, Amid Manufacturing Uncertainty, Hits The Accelerator

Automation, Amid Manufacturing Uncertainty, Hits The Accelerator

Tech May 13, 2025

Automation – robots, sensors, simulation software among other things – is speeding up even while…

Patriots’ Milton Williams Ready To Run Through The Finish Line

Patriots’ Milton Williams Ready To Run Through The Finish Line

May 13, 2025
India considering tariffs on US goods to counter Trump’s levies

India considering tariffs on US goods to counter Trump’s levies

May 13, 2025
Advice helps clients recover from dire straits

Advice helps clients recover from dire straits

May 13, 2025
Stay In Touch
  • Facebook
  • Twitter
  • Pinterest
  • Instagram
  • YouTube
  • Vimeo
Our Picks
Resurgent Financial Advisors LLC Sells 652 Shares of Amazon.com, Inc. (NASDAQ:AMZN)

Resurgent Financial Advisors LLC Sells 652 Shares of Amazon.com, Inc. (NASDAQ:AMZN)

May 13, 2025
Fashion, Not Features, Will Drive The Next Smartphone Revolution

Fashion, Not Features, Will Drive The Next Smartphone Revolution

May 13, 2025
Why The NBA Lottery Is Definitely Not Rigged

Why The NBA Lottery Is Definitely Not Rigged

May 13, 2025
ADL calls on Google shareholders to vote down human rights proposal ‘whose goal is to delegitimize Israel’

ADL calls on Google shareholders to vote down human rights proposal ‘whose goal is to delegitimize Israel’

May 13, 2025
The Financial News 247
Facebook X (Twitter) Instagram Pinterest
  • Privacy Policy
  • Terms of use
  • Advertise
  • Contact us
© 2025 The Financial 247. All Rights Reserved.

Type above and press Enter to search. Press Esc to cancel.